This page contains an archive of our research area specific eNewsletters. If you would like to be kept up to date on new products, promotions, and up and coming events, sign up to receive Novus eNews. Create a new account here, or if you already have an account, login and click on Profile.

Antibodies for Hypoxia Signaling

Research in cellular response to hypoxia started about two decades ago with the discovery of hypoxia-inducible factor /HIF-1 transcription factor, and hypoxia now is one of the most rapidly growing biomedical research sub-disciplines. Hypoxia is known to involve in several biological processes including angiogenesis, cellular survival/proliferation, metabolism, erythropoiesis, invasion/metastasis, pH regulation, multidrug resistance, stemness etc., however, it is not unrealistic to hypothesize that its implications are well beyond the current realm of scientific knowledge.   


Cellular as well as structural markers make the backbone of neuroscience experiments and Novus Biologicals scientists take the pride of developing /commercializing high quality antibodies to various neuroscience markers. Majority of our antibodies are cited in multiple publications and are established gold standards in neuroscience research. Novus antibodies for neuroscience markers are useful for qualitative as well as quantitative analysis, and some of their key features are:

  • Extremely high sensitivity and specificity
  • Validated in multiple assays and species
  • Available on fluorochrome conjugated formats also
Neurological disorders and diseases affect
millions of people annually all over the world.
They contribute significantly to the pool of
deaths caused through non-infectious
diseases and also result in a significantly
lowered quality of life with increased financial
burden. A complete understanding of the
pathogenesis and pathophysiology of these
conditions is essential for research targeting
development of effective preventive and
therapeutic measures. Antibodies useful for
qualitative and uantitative immunoassays are the key to basic as well as clinical
neurologyand many landmark discoveries have
been made in this field in the past few years.
Novus Antibodies Cited in Breast Cancer Research

Novus antibodies have been cited over 1,300 times in research relating to breast cancer and its associated diseases. We are proud to offer high quality antibodies that help researchers probe the underlying causes and possible treatments for breast cancer patients.

Cited Novus Antibodies for Breast Cancer Research


Exchange of information between neurons is accomplished via release of neurotransmitters, the chemical messengers at the presynaptic nerve terminals. Neurotransmitters then move across the neuronal synapses for recognition by neuroreceptors, the membrane receptor proteins which gets activated by neurotransmitters. A fine synchronization between the duo is required for optimal functioning of the nervous system, and analysis of neurotransmitters as well as neuroreceptors expression is very critical for physiological and pathological neuroscience experiments.